SV Health In­vestors nabs $250M to fund de­men­tia-fo­cused biotechs

SV Health In­vestors has added $250 mil­lion to its hunt for new ther­a­peu­tics for de­men­tia, Alzheimer’s and oth­er neu­rode­gen­er­a­tive dis­eases.

The Lon­don-based life sci­ences in­vestor …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER